Oculogica

Country:
USA
Founding year:
2014

Oculogica is a neurotechnology company developing software-based tools that use eye-tracking to assess neurological function following brain injury. The company focuses on objective, rapid detection of concussion and traumatic brain injury by analyzing subtle abnormalities in eye movements.

Its core platform, EyeBOX®, uses standardized visual tasks and computer vision algorithms to quantify oculomotor behavior linked to neural dysfunction. The system generates automated outputs designed to support clinical decision-making without relying on subjective symptom reporting.

Oculogica’s technology is deployed in emergency departments, sports medicine, military, and clinical settings to support concussion screening and neurological assessment. The company positions its solution as a diagnostic support tool that complements existing neurological evaluation workflows rather than a therapeutic or imaging modality.

Tools and Infrastructure
Diagnostics
Clinical Workflows

Neurofounders Insights

Modality:
Biomarkers
Form Factor:
Software/app
Interface Depth:
Software
Indication:
Head injury
Target user:
Clinicians
Regulatory stage:
FDA cleared (501k)

Non-dilutive

Oculogica is differentiated by using eye-tracking as an objective concussion biomarker, offering a fast and non-invasive alternative to symptom-based assessment. Its FDA-cleared status gives it stronger clinical footing than most digital head-injury tools.

Related companies

Articles featuring

Oculogica

No articles yet!

Press releases

No press releases published yet.